-+ 0.00%
-+ 0.00%
-+ 0.00%

*Aethlon Medical: North Immunology's Lead Program, NOR-101, Is Half-Life Extended anti-IL-13 X IL-18 Bispecific Antibody Designed to Inhibit Both Type 2 and Non-Type 2 Inflammation for Patients With Atopic Dermatitis >AEMD

Dow Jones·09/17/2026 10:36:00

Please log in to view news